TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia.
Quang VT, Podvin B, Desterke C, Tarfi S, Barathon Q, Badaoui B, Freynet N, Parinet V, Leclerc M, Maury S, Solary E, Selimoglu-Buet D, Duployez N, Wagner-Ballon O, Sloma I.
Quang VT, et al. Among authors: podvin b.
Haematologica. 2023 Nov 1;108(11):3135-3141. doi: 10.3324/haematol.2022.282528.
Haematologica. 2023.
PMID: 37102610
Free PMC article.
No abstract available.